Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: Global

National Bank Health Sciences Fund

+ Add to Watchlist

ALTHEASC:CN

28.07 CAD 0.42 1.47%

As of 07:59:30 ET on 04/27/2015.

Snapshot for National Bank Health Sciences Fund (ALTHEASC)

Year To Date: +13.97% 3-Month: +3.54% 3-Year: +27.23% 52-Week Range: 20.87 - 29.40
1-Month: -2.50% 1-Year: +33.73% 5-Year: +18.48% Beta vs SPTSX: 0.61

Mutual Fund Chart for ALTHEASC

No chart data available.
  • ALTHEASC:CN 28.07
  • 1M
  • 1Y
Interactive ALTHEASC Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for ALTHEASC

National Bank Health Sciences Fund is an open-end fund incorporated in Canada. The Fund seeks long-term capital appreciation. The Fund invests primarily in global equity securities of companies that develop, produce or distribute products or services related to health care. The Fund will target strongly managed, innovative companies.

Inception Date: 07-14-1999 Telephone: 1-514-871-7600
Managers: -
Web Site: -

Fundamentals for ALTHEASC

NAV (on 2015-04-27) 28.07
Assets (M) (on 2015-03-31) 33.69
Fund Leveraged N
Minimum Investment 500.00
Minimum Subsequent Investment 50.00

Dividends for ALTHEASC

No dividends reported

Fees & Expenses for ALTHEASC

Front Load 0.00
Back Load 0.00
Current Mgmt Fee 2.25
Redemption Fee 2.00
12b1 Fee -
Expense Ratio 2.85

Top Fund Holdings for ALTHEASC

Filing Date: 03/31/2015
Name Position Value % of Total
Roche Holding AG 9,100 3,178,338 9.433%
Johnson & Johnson 24,700 3,147,273 9.341%
Novartis AG 24,600 3,081,332 9.145%
UnitedHealth Group Inc 17,700 2,651,922 7.871%
Becton Dickinson and Co 14,100 2,564,382 7.611%
Novo Nordisk A/S 36,200 2,452,248 7.278%
Mettler-Toledo International I 5,500 2,289,474 6.795%
Varian Medical Systems Inc 18,600 2,216,644 6.579%
Essilor International SA 14,200 2,064,561 6.127%
Gilead Sciences Inc 7,700 957,044 2.840%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil